| DPRCX | RIREX | DPRCX / RIREX | |
| Total Expense Ratio | 1.91 | 0.61 | 313% |
| Annual Report Gross Expense Ratio | 2.22 | 0.61 | 364% |
| Fund Existence | 29 years | 24 years | - |
| Gain YTD | 8.815 | 9.619 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 98.8M | 131B | 0% |
| Annual Yield % from dividends | 1.83 | 2.64 | 69% |
| Returns for 1 year | 12.76 | 7.57 | 169% |
| Returns for 3 years | 31.51 | 44.26 | 71% |
| Returns for 5 years | 12.63 | 38.91 | 32% |
| Returns for 10 years | 14.13 | 69.99 | 20% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DAEMX | 21.25 | 0.22 | +1.05% |
| Dunham Emerging Markets Stock A | |||
| GSAKX | 24.24 | 0.24 | +1.00% |
| Goldman Sachs International Eq Inc A | |||
| VITNX | 126.27 | 1.06 | +0.85% |
| Vanguard MStar Inst Ttl Stk Mkt IdxInstl | |||
| PSVDX | 23.26 | 0.12 | +0.52% |
| PGIM Quant Solutions Small-Cap Val R2 | |||
| FTDZX | 208.32 | -0.45 | -0.22% |
| Franklin Biotechnology Discovery Adv | |||